An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.
Federal Policy
Posted inInsurance
4 Studies that Explain the Stakes of Medicare Open Enrollment
Leslie Walker shares four research studies to explain the stakes of Medicare open enrollment.
Posted inHealth Technology
The Next Chapter in Democratizing America’s Health Data
We talk with Micky Tripathi, the National Coordinator for Health Information Technology, about the push to give patients more access to their health care data.
Posted inInsurance
The Push to End Cancer Screening Purgatory
Initial screenings for breast, lung and cervical cancer are free, but expensive secondary tests can leave patients in screening purgatory.
Posted inInsurance
Streamlining Access to the Safety Net
Paul Shafer highlights newly federal rule aimed at streamlining application and renewal processes for enrolling in Medicaid and CHIP.
Posted inCost of Care
The Race to Prepare for Medicare’s New Drug Pricing Powers
Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.
Posted inHealth Equity
Breaking Down Biden’s New Nondiscrimination Rule
Katie Keith shares about a newly proposed rule to Section 1557, a civil rights pillar of the Affordable Care Act.
Posted inCost of Care
Dems’ New Drug Pricing Deal: What You Need to Know
Stacie Dusetzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.
Posted inMental Health
Talking 988 with The Takeaway
We share a segment from the public radio show The Takeaway featuring Dan Gorenstein talking about 988.
Posted inMental Health
Answering the Call, Part 3: America’s New Crisis Line Goes Live
In Part 3 of our special series, we hear from individuals working in their communities to prepare for the launch of 988.